3 Matching Annotations
  1. Last 7 days
    1. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis

      [Paper-level Aggregated] PMCID: PMC7785563

      Evidence Type(s): Oncogenic, Predisposing

      Justification: Oncogenic: The text indicates that 90% of the cases harbored the IDH1-R132H mutation, which is associated with conventional supratentorial IDH-mutant astrocytomas, suggesting its role in tumorigenesis. Predisposing: The mention of a personal and family history of colorectal cancer in case no. 10, along with the identification of germline mutations in MMR genes, suggests a predisposition to cancer in these cases.

      Gene→Variant (gene-first): IDH1(3417):R132H

      Genes: IDH1(3417)

      Variants: R132H

    2. To get a deeper insight into the molecular characteristics of this group, we analyzed next-generation sequencing results from 17 cases. Seven cases were analyzed using the Heidelberg 130 gene panel, six cases were sequen

      [Paragraph-level] PMCID: PMC7785563 Section: RESULTS PassageIndex: 12

      Evidence Type(s): Diagnostic, Oncogenic

      Justification: Diagnostic: The passage indicates that 90% of the cases harbored IDH1-R132H mutations, which are associated with conventional supratentorial IDH-mutant astrocytomas, suggesting a role in defining or classifying the disease. Oncogenic: The presence of IDH1-R132H mutations in the tumors suggests that this somatic variant contributes to tumor development or progression, as it is commonly found in a specific type of cancer.

      Gene→Variant (gene-first): 3417:R132H

      Genes: 3417

      Variants: R132H

    3. To get a deeper insight into the molecular characteristics of this group, we analyzed next-generation sequencing results from 17 cases. Seven cases were analyzed using the Heidelberg 130 gene panel, six cases were sequen

      [Paragraph-level] PMCID: PMC7785563 Section: RESULTS PassageIndex: 12

      Evidence Type(s): Diagnostic, Oncogenic

      Justification: Diagnostic: The passage indicates that 90% of the cases harbored IDH1-R132H mutations, which are associated with conventional supratentorial IDH-mutant astrocytomas, suggesting a role in defining or classifying the disease. Oncogenic: The presence of IDH1-R132H mutations in the tumors suggests that this somatic variant contributes to tumor development or progression, as it is commonly found in a specific type of cancer.

      Gene→Variant (gene-first): 3417:R132H

      Genes: 3417

      Variants: R132H